Article

LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating…

OncoTargets and Therapy · 2017 · Wang P, Chen D, Ma H, Li Y

Key facts

Title LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis
First author Wang P, Chen D, Ma H, Li Y
Journal OncoTargets and Therapy
Published Oct 25, 2017
DOI 10.2147/OTT.S146423
Devices mentioned K040782, K973350, K990827
Product codes mentioned JAK, JLX, KQP

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature